|
|
A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome
Sabrina Bondu
,
Anne-Sophie Alary
,
Carine Lefevre
,
Alexandre Houy
,
Grace Jung
et al.
Journal articles
inserm-02449216v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Jean-Baptiste Fraison
,
Arsène Mekinian
,
Eric Grignano
,
Jean-Emmanuel Kahn
,
Jean-Benoit Arlet
et al.
Journal articles
hal-01278608v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study
Arsène Mekinian
,
Eric Grignano
,
Thorsten Braun
,
Olivier Decaux
,
Eric Liozon
et al.
Journal articles
hal-01299293v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
Gandhi Damaj
,
Alain Duhamel
,
Marie Robin
,
Yves Beguin
,
Mauricette Michallet
et al.
Journal articles
inserm-00821506v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Gandhi Damaj
,
Rémy Gressin
,
Krimo Bouabdallah
,
Guillaume Cartron
,
Bachra Choufi
et al.
Journal articles
inserm-00868869v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia
Aline Renneville
,
Philippe Attias
,
Xavier Thomas
,
Cecile Bally
,
Sandrine Hayette
et al.
Journal articles
hal-02343942v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes
Meunier Mathieu
,
Chloé Friedrich
,
Nicolas Ducrot
,
Johanna Zannoni
,
Tondeur Sylvie
et al.
Journal articles
inserm-03874959v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes
Meunier Mathieu
,
Chloé Friedrich
,
Nicolas Ducrot
,
Johanna Zannoni
,
Tondeur Sylvie
et al.
Journal articles
hal-03876188v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Randomised Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS or Low Blast AML: GFM's "Pick a Winner" Trial, with the Impact of Somatic Mutations
Lionel Adès
,
Nicolas Duployez
,
Agnes Guerci-Bresler
,
Kamel Laribi
,
Pierre Peterlin
et al.
Journal articles
hal-03740498v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis
Odile Beyne-Rauzy
,
Marie Sebert
,
Rosa Sapena
,
Hacène Zerazhi
,
Laurence Legros
et al.
Journal articles
hal-01453321v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients
Julie Mondet
,
David Laurin
,
Caroline Lo Presti
,
Marie‐christine Jacob
,
Mathieu Meunier
et al.
Journal articles
hal-03969646v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes
Mathieu Meunier
,
Sarah Ancelet
,
Christine Lefebvre
,
Josyane Arnaud
,
Catherine Garrel
et al.
Journal articles
hal-01929396v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Nicolas Chapuis
,
Sophie Park
,
Laurent Leotoing
,
Jerome Tamburini
,
Frederique Verdier
et al.
Journal articles
pasteur-03277054v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transfer
Mathieu Meunier
,
Audrey Guttin
,
Sarah Ancelet
,
David Laurin
,
Johanna Zannoni
et al.
Journal articles
hal-03969633v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells
Julie Brault
,
Bénédicte Vigne
,
Mathieu Meunier
,
Sylvain Beaumel
,
Michelle Mollin
et al.
Journal articles
hal-02355165v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Valeria Santini
,
Jennifer Schemenau
,
Alessandro Levis
,
Enrico Balleari
,
Rosa Sapena
et al.
Journal articles
hal-00868884v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.
Shanti Natarajan-Amé
,
Sophie Park
,
Lionel Ades
,
Norbert Vey
,
Agnès Guerci-Bresler
et al.
Journal articles
hal-00771197v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
Sophie Park
,
Olivier Kosmider
,
Fréderic Maloisel
,
Bernard Drénou
,
Nicolas Chapuis
et al.
Journal articles
hal-02351432v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes. A diagnostic accuracy study.
Tatiana Raskovalova
,
Marc Berger
,
Marie-Christine Jacob
,
Sophie Park
,
Lydia Campos
et al.
Journal articles
hal-02180586v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
Jean-Baptiste Fraison
,
Arsène Mekinian
,
Eric Grignano
,
Jean-Emmanuel Kahn
,
Jean-Benoît Arlet
et al.
Blood, 2015, 126 (23), pp.1695
Journal articles
hal-01300814v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice
Eléonore Kaphan
,
David Laurin
,
Bruno Lafeuillade
,
Philippe Drillat
,
Sophie Park
et al.
Journal articles
hal-03969638v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
Sabrina Bondu
,
Anne-Sophie Alary
,
Carine Lefèvre
,
Alexandre Houy
,
Grace Jung
et al.
Journal articles
hal-03951768v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|